Main

Coporate Philanthropy

Corporate Philanthropy

Corporate Philanthropy Strategy

Corporate Philanthropy Strategy and Implementation

SK bioscience is evolving as a sustainable company by contributing to the growth of local communities through ongoing corporate philanthropy activities and enhancing its business environment. In 2022, we reorganized our corporate philanthropy strategy system and carried out philanthropic activities in three areas: ‘fostering global bio-talent’, ‘coexistence with local communities’, and ‘promotion of healthier life’, under the mission of ‘protecting public health through the establishment of a Global Biopharma Ecosystem’. We operate various programs in collaboration with social enterprises, schools, and farms in the local communities and the vulnerable to contribute to the revitalization of a healthy community ecosystem by identifying the needs of the local communities, which are the foundation of our business activities. Additionally, we leverage the unique characteristics of our business to address social issues in the medical and health fields that cannot be solely resolved through vaccines. Furthermore, we aim to fulfill our social responsibility in a broader scope by providing basic medical support to improve the health of children and adolescents not only in Korea but also overseas, and by devising programs to bridge the healthcare access gap for medically vulnerable populations.

Corporate Philanthropy Implementation

Protecting Public Health through the Formation of a Global Biopharma Ecosystem

  • Fostering Global Bio-talent

    Developing Global talent to address vaccine inequality, as well as education support for future social leaders

    • 3 good health and well-being
    • 4 quality education
    • 10 reduced inequalities

  • Coexistence with the Local Communities

    Resolving rural depopulation through cooperation with local communities based on their needs

    • 11 sustainable cities and communities
    • 17 partnerships for the ggoal

  • Promotion of Healthy Life

    Putting efforts to improve public health in areas that vaccines cannot address

    • 3 good health and well-being

Fostering Global Bio-talent

Fostering Talent through Scholarship Support

SK bioscience supports research in the healthcare field through collaborations with various global organizations and sponsorship with the goal of ‘promoting public health worldwide’. In addition, we foster global bio-talent by providing scholarships and sponsoring educational programs for exceptional individuals in the field of bio/vaccines.

  • Park Man-Hoon Scholarship

    • Department of Life Sciences at Seoul National University, Boseong High School
      → granting 10 students with KRW 5 million over a five-year period annually
    • Andong University
      → eight students will be promised KRW 2 million every year

  • Other Scholarship

    • Supporting the department of bio-vaccine engineering biotechnology of Andong University
    • Providing mentoring, education and collaborative projects, field training, curriculum collaboration, and internship experience
Global Training Hub for Biomanufacturing(GTH-B)

The World Health Organization(WHO) has designated Korea as the Global Training Hub for Biomanufacturing(GTH-B) in 2022 to address vaccine inequalities among countries. As a partner organization of the WHO, SK bioscience is dedicated to nurturing the next generation of bio-talent through providing education and on-site visits.

Shared Growth with the Local Communities

Eco-friendly Volunteer Activities

SK bioscience aims to be at the forefront of global environmental protection through eco-friendly philanthropic activities. In line with this objective, we are making efforts to internalize eco-friendly management by regularly conducting eco-friendly philanthropic activities with our employees. In 2022, we developed eco-friendly kits, organized environmental cleanup activities, and conducted a campaign to certify eco-friendly practices.

Eco-friendly Volunteer Activities

SK bioscience, together with its three affiliated companies, SK chemicals, SK gas, and SK plasma, operated ‘Happy Green School’ Program in elementary schools located in Seongnam, Ulsan, Andong, and Cheongju. Our employees took on the role of daily teachers, providing eco-friendly education at a child’s level, helping students understand the importance of the environment in an easy and fun way. In 2022, the program was conducted in 237 classrooms, and in 2023, we have set a goal to expand the program to 270 classrooms. We plan to support education on topics such as microplastics and eco-friendly technologies.

Hope Maker Program

This mentoring/sponsorship program is SK bioscience’s representative philanthropic initiative for children and adolescents from low-income families. Since 2012, we have been providing financial support to participants in the Hope Maker program, including regular monthly donations, holiday gifts, cold weather gear kits, and high school graduation gifts. Additionally, we offer emotional support through academic guidance and career counseling provided by college student mentors. Each year, we engage in ongoing discussions with local welfare centers to develop programs that address the specific needs of the students

Community Sponsorship

SK bioscience has been actively supporting the growth of Andong City, where Andong L HOUSE is located. In an effort to revitalize the community following the declaration of the end of COVID-19, we provided support for the Andong Citizens’ Athletic Competition and sponsored forums aimed at promoting Korean spiritual culture and humanistic values.

Promoting Healthier Life

Blood Donation Campaign

SK bioscience conducted a blood donation campaign, known as the Second Life activity, in response to the significant decrease in individual and group blood donations. The decrease was caused by the prolonged COVID-19 pandemic, which resulted in challenges in maintaining an adequate blood supply. In 2023, we will continue organizing blood donation campaigns to contribute towards addressing this social issue.

Jigwanseoga

Since 2022, SK bioscience has been actively working towards establishing a small library in the form of a book cafe, providing a space where local citizens can stop by to read, reflect, and relax. We are currently preparing to open the first library at Andong L HOUSE in 2023, with the aim of creating cultural infrastructure in the local community and fostering a humanities ecosystem through community revitalization. Additionally, we hope that this initiative will contribute to improving the mental health of local citizens.

  • Number of Employees joined Our philanthropic activities

    429persons

  • Spent hours

    1035.5hours

Fulfilling Social Responsibility by Creating a Global Bio-ecosystem

Supporting Shared Growth of the Global Bio Industry

To contribute to global public health, SK bioscience supports the growth of stakeholders in the bio-industry to promote shared growth in each area. We will continue to strive to become a company that generates social value through investments in bio ventures, collaborative research and development to advance bio technologies, nurturing professionals, and supporting global initiatives and local communities.

Supporting the growth of Bio-ventures

SK bioscience has expanded its investment in vaccine and infectious disease-related bio-tech by establishing an investment fund. By doing so, we are contributing to the revitalization of the bio-venture ecosystem and creating opportunities for new revenue-generating businesses.

Investment Review Process
투자 검토 프로세스, 자세한 내용은 아래를 참고해주세요
Hosting Park Man-Hoon Award Ceremony

In honor of our late Vice Chairman Park Man-hoon, who made significant contributions to our research capabilities through his dedication to vaccines and R&D, SK bioscience, together with the International Vaccine Institute, established the Park Man-hoon Award. This prestigious award aims to recognize individuals and organizations for their outstanding contributions to global health. In April 2023, the second Park Man-hoon Awards were presented to Dr. Rino Rappuoli and Dr. Mariagrazia Pizza from Italy, who have developed new scientific approaches in vaccine development. Additionally, Professor Andrew Pollard and Professor Sarah Gilbert from the University of Oxford were jointly recognized for their groundbreaking research on novel vaccines for COVID-19 and other areas of global health.

Basic Research Support

SK bioscience collaborates closely with the International Vaccine Institute(IVI) in pursuit of our shared objective to promote global public health. We have pledged to donate KRW 3 billion to IVI for three years from 2022 to support vaccine R&D equipment and research. In this way, we aim to make further advancements to the vaccine R&D environment by supporting organizations involved in all stages of the value chain, from development to distribution of vaccines. SK bioscience has also established an industryacademia collaboration system for infectious disease response at Korea University Medical Center. As a result, we will jointly establish an infectious disease surveillance system and conduct joint vaccine research for the next three years. Furthermore, we have allocated KRW 5 billion to support research on emerging infectious diseases.

  • RIGHT Fund sponsorship

    • Joint investment with five domestic life science companies and the Bill & Melinda Gates Foundation(BMGF)
    • Pledged to invest approximately KRW 100 billion in R&D projects over the next five years since 2018

  • International Vaccine Institute(IVI) sponsorship

    • Empowerment through the IVI network and expertise
    • Sponsorship of International Vaccine Advanced Course
    • Park Man-Hoon Award

  • Research support

    • Support for advances in basic research
    • Established an industryacademia collaboration system for infectious disease response at Korea University Medical Center